Evidence map›Paper›PMID 33118913›Full record

ArticleBJPsych open2020

Priority concerns for people with intellectual and developmental disabilities during the COVID-19 pandemic.

Sam Tromans, Michael Kinney, Verity Chester, Regi Alexander, Ashok Roy, Josemir W Sander, Harry Dudson, Rohit Shankar

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BJPsych open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06238089 (A Novel Way to Understand and Communicate the Burden of Antipsychotic Prescribing for Adults Across Specialist Intellectual Disability Services in England and Wales.), which is not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06238089 unknown statusnot on this mapstarted 2023, after this paper: background citation

A Novel Way to Understand and Communicate the Burden of Antipsychotic Prescribing for Adults Across Specialist Intellectual Disability Services in England and Wales.

TypeobservationalSponsorUniversity of PlymouthRan2023 to 2024Enrolled600ConditionsIntellectual Disability
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Sam TromansLeicestershire Partnership NHS Trust, UK; and Department of Health Sciences, University of Leicester, UK.
Michael KinneyBelfast Health and Social Care Trust, UK.
Verity ChesterHertfordshire Partnership University NHS Foundation Trust, UK; and Norwich Medical School, University of East Anglia, UK.
Regi AlexanderHertfordshire Partnership University NHS Foundation Trust, UK; and University of Hertfordshire, UK.ORCID https://orcid.org/0000-0002-3554-2948
Ashok RoyCoventry and Warwickshire Partnership NHS Trust, UK; and University of Warwick, UK.ORCID https://orcid.org/0000-0002-8432-981X
Josemir W SanderUCL Queen Square Institute of Neurology, UK; Chalfont Centre for Epilepsy, UK; and Stichting Epilepsie Instellingen Nederland (SEIN), the Netherlands.
Harry DudsonDepartment of Health Sciences, University of Leicester, UK.
Rohit ShankarCornwall Partnership NHS Foundation Trust, UK; and University of Exeter Medical School, Truro, UK.ORCID https://orcid.org/0000-0002-1183-6933
University of Leicester · GBBelfast Health and Social Care Trust · GBNational Hospital for Neurology and Neurosurgery · GBUniversity of East Anglia · GBUniversity of Exeter · GBUniversity of Hertfordshire · GBUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe approach taken to support individuals during the coronavirus disease 2019 (COVID-19) pandemic needs to take into account the requirements of people with intellectual disabilities and/or autism, who represent a major vulnerable group, with higher rates of co-occurring health conditions and a greater risk of dying prematurely. To date, little evidence on COVID-related concerns have been produced and no report has provided structured feedback from the point of view of people with intellectual disabilities and/or autism or of their family/carers.

aimsTo provide systemised evidence-based information of the priority concerns for people with intellectual disabilities and/or autism regarding the COVID-19 pandemic.

methodSenior representatives of major UK-based professional and service-user representative organisations with a stake in the care of people with intellectual disabilities and/or autism were contacted to provide a list of concerns across three domains: 'mental health and challenging behaviour', 'physical health and epilepsy' and 'social circumstances and support'. The feedback was developed into statements on frequently reported priorities. These statements were then rated independently by expert clinicians. A video-conference meeting to reconcile outliers and to generate a consensus statement list was held.

resultsThirty-two organisations were contacted, of which 26 (81%) replied. From the respondent's data, 30 draft consensus statements were generated. Following expert clinician review, there was initially strong consensus for seven statements (23%), increasing to 27 statements (90%) following video conferencing.

conclusionsThese recommendations highlight the expectations of people with intellectual disabilities and/or autism in the current pandemic. This could support policymakers and professionals' deliver and evidence person-centred care.

Indexed as

autismCOVID-19developmental disabilityintellectual disability

Identifiers

PMID33118913
PMCPMC7609203
OpenAlexW3095620837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.